DEAFinal Rule
Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I
HealthcareOther
Ad Space (leaderboard)
Summary
The Drug Enforcement Administration (DEA) has extended the temporary ban on five synthetic drugs—clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam—keeping them classified as Schedule I controlled substances, meaning they cannot be legally manufactured, distributed, or possessed. These drugs are designer versions of anti-anxiety medications that are sold illegally and pose public health risks, so the DEA is maintaining restrictions on them while deciding on a permanent classification.
Key Points
- 1Five synthetic drugs that mimic prescription anti-anxiety medications have been temporarily banned and moved to Schedule I, the most restrictive category for controlled substances
- 2These drugs are illegal to make, sell, or possess; violations can result in federal criminal penalties including prison time and fines
- 3The DEA extended a temporary ban rather than making it permanent, meaning the agency is still reviewing these drugs but keeping them off the market in the meantime
- 4These substances are often sold online or through illicit channels and pose health risks because their strength and purity are unregulated and unknown
- 5The ban affects drug manufacturers, distributors, and individuals who possess these drugs; people using them illegally could face federal prosecution
Key Dates
Published
July 25, 2025
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.
The Digest Network
Ad Space (rectangle)